Results 11 to 20 of about 391,281 (216)

Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia

Emerging Microbes and Infections, 2023
Although previous studies have reported the dysregulation of respiratory tract microbiota in infectious diseases, insufficient data exist regarding respiratory microbiota imbalances in the lower respiratory tracts (LRTs) of children with Mycoplasma ...
Ya-cui Wang, Xiaoran Yu, Fang Liu, Xue Tian, Shuting Quan, A. Jiao, Xuemei Yang, Xianfen Zeng, W. Jiao, Hui Qi, Fang Xu, Qin-jing Li, Shuping Liu, Bao-Ping Xu, Lin Sun, A. Shen   +15 more
semanticscholar   +1 more source

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children

Clinical Respiratory Journal, 2023
Thromboembolism is less common in children than in adults, but it is frequently associated with Mycoplasma pneumoniae infection in many cases. This study aimed to investigate the clinical characteristics of pediatric M.
Lanqin Chen, J. Yin, Xiu-yun Liu, Jun Liu, Bao-Ping Xu, Kunling Shen   +5 more
semanticscholar   +1 more source

Epidemiological features of community-acquired mycoplasma pneumonia

Фундаментальная и клиническая медицина, 2021
Aim. To analyse an epidemic process of community-acquired mycoplasma pneumonia in the Volga Federal District and the Nizhny Novgorod Region.Materials and Methods.
E. A. Koshkarina, O. A. Strazhnova, M. A. Sharabakina, O. M. Chekanina, V. V. Krasnov, P. G. Zubarov, O. V. Kovalishena   +6 more
doaj   +1 more source

Analysis of cytokine levels, cytological findings, and MP‐DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia

Immunity, Inflammation and Disease, 2023
The present study was conducted to determine the inflammatory response in the lungs of children with Mycoplasma pneumoniae pneumonia (MPP).
Fang Deng, Huiling Cao, Xiaohua Liang, Qubei Li, Yang Yang, Zhi-Rong Zhao, Jun-jie Tan, G. Fu, Chang Shu   +8 more
semanticscholar   +1 more source

Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management

Journal of Clinical Medicine, 2022
Refractory Mycoplasma pneumoniae pneumonia (RMPP) is a severe state of M. pneumoniae infection that has attracted increasing universal attention in recent years. The pathogenesis of RMPP remains unknown, but the excessive host immune responses as well as
L. Tong, Shumin Huang, Chen Zheng, Yuanyuan Zhang, Zhimin Chen   +4 more
semanticscholar   +1 more source

Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020

Emerging Microbes and Infections, 2022
The objective of this paper is to explore the characteristics of Mycoplasma pneumoniae (MP) epidemics in Beijing, China. Patients with acute respiratory tract infection (ARTI) were enrolled from 35 sentinel hospitals in Beijing, 2015–2020.
Xue Wang, Maozhong Li, M. Luo, Q. Luo, Lu Kang, Hui Xie, Yi-ting Wang, Xiali Yu, Aihua Li, M. Dong, F. Huang, C. Gong   +11 more
semanticscholar   +1 more source

Distribution difference of T lymphocyte subsets in common and refractory mycoplasma pneumonia and its impact on clinical treatment [PDF]

Jichu yixue yu linchuang
Objective To investigate the distribution difference of T lymphocyte subsets in common and refractory mycoplasma pneumonia and its impact on treatment. Methods Two hundred children with mycoplasma pneumonia hospitalized from October 2023 to January 2024 ...
ZHU Lin, FU Shuqin, JIA Wanyu, GUO Caili, SONG Chunlan
doaj   +1 more source

Acute saddle pulmonary embolism: A rare complication of mycoplasma pneumonia

Respiratory Medicine Case Reports, 2020
Background/Introduction: Mycoplasma pneumonia affects 1% of the population in the United States. The majority of patients infected with Mycoplasma experience upper respiratory tract infection symptoms, and about 10% of patients infected with Mycoplasma ...
Farrah Chilet, Arshad Muhammad Iqbal, Nikolay Mitzov, Abdulmagid Eddib, Salman Muddassir   +4 more
doaj   +1 more source

Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study

Journal of Clinical Medicine, 2022
Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and the treatment of choice is macrolides. There is an increasing trend in reports of refractory clinical responses despite macrolide treatment due to the ...
Yunjung Choi, E. Chung, Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, B. Kim, H. Kim, Y. Cho, Ju-Hee Seo, I. Sol, M. Sung, D. Song, Y. Ahn, H. Oh, Jinho Yu, Sungsu Jung, K. Lee, Ju Suk Lee, G. Jang, Y. Jang, H. Chung, S. Choi, M. Han, J. Shim, Jin Tack Kim, Chang-Keun Kim, H. Yang, D. Suh   +28 more
semanticscholar   +1 more source

Development of a Nomogram for Predicting Refractory Mycoplasma pneumoniae Pneumonia in Children

Frontiers in Pediatrics, 2022
Background In children, refractory Mycoplasma pneumoniae pneumonia (RMPP) may result in severe complications and high medical costs. There is research on a simple and easy-to-use nomogram for early prediction and timely treatment of RMPP.
Fangfang Shen, C. Dong, Tongqiang Zhang, Changjiang Yu, Kun Jiang, Yongsheng Xu, J. Ning   +6 more
semanticscholar   +1 more source